China's traditional Chinese medicine industry enters the capital era

It is reported that in 2013, the domestic traditional Chinese medicine market is in a dynamic and stable state, with new signs, new forces and new hopes emerging constantly, injecting new driving forces into the industry Among them, capital power can not be ignored, and even has become one of the main reasons for maintaining the high-level operation of the domestic traditional Chinese medicine industry in 2013 On the whole, in 2013, the domestic traditional Chinese medicine market, the idea of "Combing" with rectification and standardization as the main line runs through, which can also be called the annual theme words This sort of "Combing" takes place in the context of the era when the traditional Chinese medicine industry has entered the golden age of the big health industry (1318.00, - 3.90, - 0.30%) At the supply side, the supply chain of traditional Chinese medicine production has experienced the prosperity in the early stage of the market economy, the chaos in the middle stage, and has moved to the key node in the mature stage of the market economy At the demand side, there is a strong demand for high-quality traditional Chinese medicine raw materials With the joint efforts of both supply and demand, the domestic Chinese herbal medicine market in 2013 is in a dynamic and stable state, with new signs, new forces and new hopes emerging constantly, injecting new driving force into the industry Among them, capital power can not be ignored, and even has become one of the main reasons for maintaining the continuous high-level operation of the domestic Chinese herbal medicine industry in 2013 It can be seen that the "marriage" of capital and resources has become the norm After reasonable guidance and transparent regulation, resource economy will become a new economic growth point of Chinese medicine industry, and also a "rich gold mine" that the industry "tycoons" are competing for From a technical point of view, the overall trend of the domestic Chinese herbal medicine market in 2013 opened in a low-key manner, ended at a high level, and reversed a number of bearish forecasts in the early stage Among them, there are even large varieties "stars" such as ginseng, angelica, dangshen and Yuanhu, as well as small varieties such as Kochia and Sinapis, which once again confirmed the iron rule of "no lack of gold, no lack of mud and sand" in the pharmaceutical market However, the varieties such as Pseudostellaria, Panax notoginseng and lilies, which have declined significantly, also constantly warned that the imbalance of production and marketing caused by information asymmetry in the industry still exists Based on the operation of the comprehensive 200 index, combined with the current domestic labor cost, the price ratio of medicine and food, capital settlement and other factors, it is expected that the domestic medicine market in the new year will remain at a relatively high level in history; however, the accumulated land area and old inventory in the high price period of the first three years of the medicine market will certainly bring great pressure on the market Therefore, even if there is a large amount of capital to enter, the main style of the operation of the comprehensive 200 index in 2014 is "stable and declining" In 2013, there was an increase in stability, and capital strength was beginning to show Judging from the operation of the comprehensive 200 index, there were several key points worthy of attention in 2013: the opening point was 2431, the highest point was 2661, the lowest point was 2431, and the average point was 2582 Compared with 2582 in 2013 and 2230 in 2012, it can be seen that the overall drug market in 2013 showed a steady upward trend, with an increase of 15.79% on month After nearly 3 years of adjustment, part of the surplus old stock has been well digested, and the price bubbles of most varieties have been released in the early adjustment, resulting in the recovery of the market in 2013 Although the opening point of the index in 2013 has also become the lowest point of the year, the "dual identity" of this point can better explain the fact that the overall recovery of the drug market But the index is still weak in the rally in the middle and later part of this year In 2013, the difference between the highest point and the lowest point of the index was 230 Based on the lowest point of 2431, the growth rate was only 9% The main reason for the narrow fluctuation was that more varieties were still in the situation of supply exceeding demand, and the burden of digesting inventory slowed down the growth of the index The index operation in 2013 is basically consistent with the market fluctuation For example, the highest point appeared in April 2013, which is a period of vigorous movement of large quantities of Chinese herbal medicines Meanwhile, it is directly related to the upward pull of prices of angelica, ginseng and other varieties However, after September 2013, affected by the price drop of Panax notoginseng, Cordyceps and other varieties, the index showed a significant low platform period from September to October In the whole year of 2013, there are also several key points affecting the operation of the domestic Chinese herbal medicine market, which are "great health, quality gate, capital strength, purge storm and supporting system" Driven by h7n9 public health events and health service industry policies, great health is full of heat, and traditional Chinese medicine is its core industry, which means the golden age of traditional Chinese medicine industry is coming, and also means the strong demand for safe and stable supply of traditional Chinese medicine Quality gate and purge storm are also not to be ignored In 2013, the quality problems of traditional Chinese medicine frequently appeared in the domestic traditional Chinese medicine industry The national efforts to rectify the chaos in the market of traditional Chinese medicine and regulate the purge of the circulation system of traditional Chinese medicine have brought a huge impact on the development of the field of traditional Chinese medicine At the same time, the relevant national supporting systems are gradually improving, such as the Ministry of industry and information technology supports the construction of 36 large-scale standardized production bases of traditional Chinese medicine, the establishment of the national resource center of traditional Chinese medicine, the establishment of the national dynamic monitoring and service system of traditional Chinese medicine resources, the realization of the third-party settlement of the e-commerce platform of traditional Chinese medicine, etc., with obvious industrial purification effect However, it is a systematic project to purify, standardize and reconstruct the modern production and marketing service chain of traditional Chinese medicine It is not a single action, single department or single force that can be completed after one battle It needs not only the support of policies and scientific and technological forces, but also the extensive participation of market and capital forces In this respect, the industry e-commerce platform plays an important role of linking and bearing, which is the core of the whole modern service system of traditional Chinese medicine However, capital power plays an important role in the development of Chinese herbal medicine industry in 2013 The prices of Panax notoginseng, ginseng, angelica and other bulk varieties remain high In addition to the relative imbalance of production and marketing, it has a direct causal relationship with the large amount of capital support behind them In the game between strong capital and weak resources, resources are obviously in the downwind Therefore, the traditional concept has always believed that the crime of hoarding and speculation is inexcusable However, what is the development prospect of an industry that does not even want capital? The key is to provide a transparent, standardized and reasonable access for social capital, and a perfect docking platform for enterprises to participate in raw material production and supply, so that resources and capital can achieve positive interaction and mutual promotion In 2014, there was a steady decline According to the forecast, capital intervention started at 2614 points in 2014 and ended at 2585 points The maximum point is 2667, and the minimum point is 2508 At the time of opening, it was still in the peak season of sales in the overall drug market, but the peak season of 2014 caused by the market situation in 2013 has been formed, so it is difficult to rebound; it is expected that with the arrival of the market off-season in May 2014, the market will inevitably decline, and the index in the off-season will fluctuate and adjust as a whole; the market is stimulated by the short-term recovery of the overall market in 2013, plus With the timely emergence of the hot spot factors, there is still a upward warming momentum in the middle of 2014 After October 2014, because the recovery of market price in 2013 will cause the output of some 1-year-old varieties of some families to surge again and some wild resources are not yet scarce, the high price in 2013 will stimulate farmers to actively harvest It is expected that the index will fall again in a short time after the relevant output increases substantially On the whole, 2014 is not going to be a peaceful year under the premise of deepening industrial reform and governance On the one hand, the medium-term and long-term planning of the national traditional Chinese medicine industry, which has been brewing for nearly two years, is expected to be formally finalized at the beginning of the year, and the construction of a modern production and supply guarantee system for traditional Chinese medicine will certainly become the top priority of the whole planning; information service platform, dynamic monitoring of traditional Chinese medicine resources, e-commerce platform and warehousing logistics platform should be the core content of the system; and the traditional Chinese medicine industry, which has called for many years, is expected to be finalized Insurance, strategic reserves and other measures are also expected to be introduced On the other hand, as the product of the early stage of market economy, traditional Chinese medicine market has completed the historical task of industry transformation from planned economy to market economy, and only time is left for its gradual withdrawal from the historical stage However, under the condition that the new circulation system has not been fully established, it will become a normal practice to continuously strengthen the rectification, strict control and purification of traditional Chinese medicine market Therefore, the days of extensive and backward traditional trade will be more and more difficult It is worth noting that capital intervention will continue to have a huge impact As the saying goes in the pharmaceutical market, "business is not as good as business, business is not as good as lying down." Under the background of the declining traditional trade mode characterized by "doing business and sitting on business", the way of "lying business management" with hoarding and speculation as a means of profit will become increasingly fierce Coupled with the strong intervention of large enterprises and external hot money, the supply of raw materials for traditional Chinese medicine will face severe challenges On the one hand, this kind of business will force pharmaceutical enterprises to go to the source of production and guarantee their own raw material supply by means of production and marketing docking and production base; on the other hand, it will maintain the relatively high price of raw materials of traditional Chinese medicine, so as not to fall into the historical strange circle of "big up and big down" again At the same time, the increasing importance of traditional Chinese medicine raw materials and the strong desire of capital to intervene in the industry will stimulate the knowledgeable enterprises to open the whole industry chain of traditional Chinese medicine industry as soon as possible Make full use of modern e-commerce platform, financing platform and other means to integrate and structure resources, finance, finished product sales and so on, and finally build the "aircraft carrier" of traditional Chinese medicine industry Therefore, the era of great health is coming with explosive growth, so the traditional Chinese medicine industry is also facing unprecedented development opportunities In the face of opportunities, the supply side of raw materials for traditional Chinese medicine as the material basis is far from ready Traditional Chinese medicine, a thousand year old traditional industry, has made us toss for too long and look forward to too long However, from the perspective of many positive energy in 2013, the accumulated disadvantages are being solved continuously in the development; in 2014, this positive energy will be accelerated to enlarge and further promote the upgrading of the industry.